Macrophages were either immunosuppressive, showing up-regulation of markers previously associated with an immunosuppressive phenotype in GBM myeloid cells (CD163 and CD206) (11, 18, 22, 23), or proinflammatory. The gene discussed is MRC1; the disease is glioblastoma.